Screening for Familial Ovarian Cancer: Failure of Current Protocols to Detect Ovarian Cancer at an Early Stage According to the International Federation of Gynecology and Obstetrics System
- 20 August 2005
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (24), 5588-5596
- https://doi.org/10.1200/jco.2005.05.097
Abstract
Purpose To assess the effectiveness of annual ovarian cancer screening (transvaginal ultrasound and serum CA-125 estimation) in detecting presymptomatic ovarian cancer in women at increased genetic risk. Patients and Methods A cohort of 1,110 women at increased risk of ovarian cancer were screened between January 1991 and March 2004; 553 were moderate-risk individuals (4% to 10% lifetime risk) and 557 were high-risk individuals (> 10% lifetime risk). Outcome measurements include the number and stage of screen-detected cancers, the number and stage of cancers not detected at screening, the number of equivocal screening results requiring recall/repetition, and the number of women undergoing surgery for benign disease. Results Thirteen epithelial ovarian malignancies (12 invasive and one borderline), developed in the cohort. Ten tumors were detected at screening: three International Federation of Gynecology and Obstetrics (FIGO) stage I (including borderline), two stage II, four stage III, and one stage IV. Of the three cancers not detected by screening, two were stage III and one was stage IV; 29 women underwent diagnostic surgery but were found not to have ovarian cancer. Conclusion Annual surveillance by transvaginal ultrasound scanning and serum CA-125 measurement in women at increased familial risk of ovarian cancer is ineffective in detecting tumors at a sufficiently early stage to influence prognosis. With a positive predictive value of 17% and a sensitivity of less than 50%, the performance of ultrasound does not satisfy the WHO screening standards. In addition, the combined protocol has a particularly high false-positive rate in premenopausal women, leading to unnecessary surgical intervention.This publication has 29 references indexed in Scilit:
- Biology of Epithelial Ovarian Cancer: Implications for Screening Women at High Genetic RiskJournal of Clinical Oncology, 2004
- Results from an ultrasound‐based familial ovarian cancer screening clinic: a 10‐year observational studyUltrasound in Obstetrics & Gynecology, 2003
- Management of familial ovarian cancerPublished by Cambridge University Press (CUP) ,2002
- Screening for familial ovarian cancerPublished by Cambridge University Press (CUP) ,2002
- Overview of the clinical genetics of ovarian cancerPublished by Cambridge University Press (CUP) ,2002
- Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomyInternational Journal of Cancer, 2002
- Use of CA-125 and ultrasound in high-risk womenInternational Journal of Gynecologic Cancer, 2002
- Screening women with a family history of breast cancer—results from the British Familial Breast Cancer GroupEuropean Journal of Surgical Oncology, 2000
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Early detection of familial ovarian cancerEuropean Journal of Cancer, 1996